»
Antibody
»
anti-P21-WAF1
P21/WAF1 antibody
| Antigen |
|
| Clonality |
Monoclonal (WA-1) |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
Alternatives Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA, Immunocytochemistry (ICC)
|
| Catalog no. |
ABIN94444 |
| Quantity |
0.1 mg (1 mg/ml) |
| Price |
286.00 $ Plus shipping costs $35.00
|
| Shipping to |
|
| Availability |
Ships within 3 to 5 Business days |
|
Alternative name
|
p21Waf1
|
|
Immunogen
|
Human p21 protein
|
|
Format
|
Purified
|
|
Isotype
|
IgG1 (Matching secondary antibodies)
|
|
Clone
|
WA-1
|
|
Description
|
The tumour suppressor p21Waf1 (Wild-type p53-Activated Fragment 1, also known as Cip1,Cdk interacting protein, or SDI 1) is a cyclin-dependent kinase (Cdk) inhibitor, which isexpressed by involvement of p53, Egr-1, AP2, STATs or other transcription factors uponvarious stimuli resulting in cell cycle arrest. Through its N-terminal domain p21Waf1 inhibitsCdk activity, whereas through the C-terminal domain it inhibits the activity of PCNA(proliferating cell nuclear antigen) to activate DNA replication. Cytosolic location of p21counteracts its inhibitory activities.
|
|
Specificity
|
The antibody WA-1 reacts with p21 protein (Waf1, Cip1, SDI 1), a 21 kDa tumoursuppressor, which inhibits the activity of cyclin-dependent family kinases and of proliferatingcell nuclear antigen.
|
|
Application Notes
|
Immunohistochemistry (paraffin sections) - Positive tissue: colon carcinomaImmunocytochemistryELISA
|
|
Concentration
|
1 mg/ml
|
|
Purity
|
> 95% (by SDS-PAGE)
|
|
Purification
|
Purified from ascites by precipitation methods.
|
|
Buffer
|
Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
|
|
Storage
|
Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles.
|
|
Restrictions
|
For Research Use only
|
Alternatives for antigen "P21/WAF1", type "Antibodies"